Hypoxia-Inducible Protein 2 ( <i>HIG2</i> ), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy (2006)

No AccessJournal of UrologyAdult urology1 Apr 2006Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy A. Togashi, T. Katagiri, S. Ashida, T. Fujioka, O. Maruyama, Y. Wakumoto, Y. Sakamoto, M. Fujime, Y. Kawachi, T. Shuin, and Y. Nakamura A. TogashiA. Togashi Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan , T. KatagiriT. Katagiri Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan , S. AshidaS. Ashida Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan , T. FujiokaT. Fujioka Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan , O. MaruyamaO. Maruyama Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan , Y. WakumotoY. Wakumoto Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan , Y. SakamotoY. Sakamoto Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan , M. FujimeM. Fujime Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan , Y. KawachiY. Kawachi Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan , T. ShuinT. Shuin Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan , and Y. NakamuraY. Nakamura Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)01030-XAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy." The Journal of Urology, 175(4), p. 1272 © 2006 by American Urological AssociationFiguresReferencesRelatedDetails Volume 175Issue 4April 2006Page: 1272 Advertisement Copyright & Permissions© 2006 by American Urological AssociationMetrics Author Information A. Togashi Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan More articles by this author T. Katagiri Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan More articles by this author S. Ashida Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan More articles by this author T. Fujioka Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan More articles by this author O. Maruyama Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan More articles by this author Y. Wakumoto Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan More articles by this author Y. Sakamoto Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan More articles by this author M. Fujime Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan More articles by this author Y. Kawachi Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan More articles by this author T. Shuin Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan More articles by this author Y. Nakamura Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo Department of Urology, Juntendo University School of Medicine, Tokyo Department of Urology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku Department of Urology, Iwate Medical University, Morioka Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan More articles by this author Expand All Advertisement PDF downloadLoading ...